Vol. 9 No. 1 (2017): Archives of Public Health
Public Health

Incidence and prevalence of thyroid carcinoma in Republic of Macedonia (1999-2010)

Тања (Tanja) Маказлиева (Makazlieva)
Institute for Pathophysiology and Nuclear Medicine, Medical Faculty, University "Sts. Cyril and Methodius", Skopje
Оливија (Olivija) Васкова (Vaskova)
Институт за патофизиологија и нуклеарна медицина, Медицински факултет, Универзитет "Св. Кирил и Методиј", Скопје
Тони (Toni) Трипуноски (Tripunoski)
Институт за патофизиологија и нуклеарна медицина, Медицински факултет, Универзитет "Св. Кирил и Методиј", Скопје
Венјамин (Venjamin) Мајсторов (Majstorov)
Институт за патофизиологија и нуклеарна медицина, Медицински факултет, Универзитет "Св. Кирил и Методиј", Скопје

Published 2017-08-19

Keywords

  • thyroid carcinoma,
  • epidemiology,
  • incidence rate,
  • prevalence rate,
  • mortality

How to Cite

1.
Маказлиева (Makazlieva) Тања (Tanja), Васкова (Vaskova) Оливија (Olivija), Трипуноски (Tripunoski) Тони (Toni), Мајсторов (Majstorov) Венјамин (Venjamin). Incidence and prevalence of thyroid carcinoma in Republic of Macedonia (1999-2010). Arch Pub Health [Internet]. 2017 Aug. 19 [cited 2024 Mar. 28];9(1):66-73. Available from: https://id-press.eu/aph/article/view/1259

Abstract

Epidemiological data indicates that  thyroid carcinoma (TC)  is the most frequent endocrinological tumors, participating with around 1%  from all malignomas. Because of lack of published papers related to the epidemiological data for TC in the last two decades in our country especially after the introduction of corrected Iodine prophylaxis program, with new higher Iodine supplementation in 1999, there is a need for publishing real scientific view of the epidemiological situations. The aim of the study was to present epidemiological data on incidence and prevalence rate of TC in R Macedonia for the period 1999-2010. Materials and methods: A retrospective analysis of medical data from all diagnosed and treated TC at the Institute of Pathophysiology and Nuclear Medicine during the period 1999-2010 was performed. The Institute is the only Center performing treatment  of TC with 131I, therefore the registered epidemiological data are representative for the country. Statistical State Office data from the census in 1994 and 2002 were used to calculate annual incidence and prevalence rate as well as geographical and ethnic country distribution of TC. Results: During 12-year period, a total of 204 TC cases were registered, with prevalence rate of 10.15/105. The highest incidence rate was detected in 2000  (1.18/105) followed by reduction in 2003 (0,49/105). Annual incidence rate showed continuously higher incidence rate in the period 2006-2010 with average incidence rate of 0.98/105. Results indicate quite similar incidence rate among the three ethnic groups while the regional distribution indicates the  highest prevalence in Skopje region, East and Northeast region than Southwest region. The lowest prevalence rate was registered in Polog, Southeast and Pelagonia region. Conclusions: According to the analyzed data from the diagnosed patients with TC during the period1999 – 2010, there is increase in the incidence and prevalence rate, but however compared with the literature is still very low. Major differences in morbidity rate concerning the ethnic distribution were not found. Related to the geographical distribution of TC in eight regions, the highest prevalence rate was found in northern and eastern parts, while the lowest in western territories. Further analyzes are needed to compare it with the previous epidemiological data in the country, as well as an analysis for possible environmental effects for the low incidence rate, compared to those from literature.

Downloads

Download data is not yet available.

References

  1. Burns WR, Zeiger MA. Differenti- ated thyroid cancer. Semin Oncol
  2. ;37(6):557-66.
  3. Davies L, Gilbert Welch H. In- creasing incidence of thyroid can- cer in the United States.1973-2002. JAMA 2006; 295(18):2164-2167.
  4. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five conti- nents, Vol. IX. Lyon: IARC Scien- tific Publications No 160; 2007.
  5. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF et al. SEER Cancer Statistics Re- view, 1975-2012, National Cancer Institute. Bethesda, MD, http:// seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted to the SEER web site, April 2015.
  6. McHenry CR, Phitayakorn R. Fol- licular adenoma and carcinoma of thyroid gland. The Oncologist
  7. ; 16:585-593.
  8. Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head and Neck Pathol
  9. ; 5:51–56.
  10. Li Volsi VA. Papillary thyroid car- cinoma: an update. Modern Pa- thology (2011) 24, S1–S9.
  11. Girardi FM, Barra MB, Zettler CG.
  12. Variants of papillary thyroid car- cinoma: association with histo- pathological prognostic factors, Braz J Otorhinolaryngol 2013;
  13. (6):738-44.
  14. Slijepcevic N, Zivaljevic V, Marink- ovic J, Sipetic S, Diklic A, Paunovic I. Retrospective evaluation of the incidental finding of 403 papillary thyroid microcarcinomas in 2466 patients undergoing thyroid sur- gery for presumed benign thyroid disease. BMC Cancer 2015;15:330.
  15. Mulla ZD, Margo CE. Primary ma- lignancies of the thyroid. Ann Ep- idemiol 2000; 10:24-30.
  16. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. World- wide increasing incidence of thy- roid cancer: Update on epidemi- ology and risk factors. Journal of Cancer Epidemiology, Vol 2013,
  17. ;1-10.
  18. State statistical office of R Mac- edonia, Regions of the Republic Macedonia, 2009. ISSN 1857-6141,
  19. http://w w w.stat.gov.mk/P u blik- acii/GodisnikRegioni2009.pdf
  20. Haugen BR, Alexander EK, Bi- ble KC, Doherty GM, Mandel SJ, Nikiforov YE et al. American thy- roid association management guidelines for adult patients with thyroid nodules and differ- entiated thyroid cancer. Thyroid
  21. ;26(1):1-133.
  22. Schumberger M, Pacini F, Tutle RM. Thyroid tumors, Forth edi- tion, Paris: Institute Medico-Edu- catif, 2015.
  23. Cancer Research UK, Thy- roid cancer statistics http:// w w w .canc e rresearc huk.o rg/ health-professional/cancer-sta - tistics/statistics-by-cancer-type/ th yro id-canc e r#heading - Ze ro ,
  24. КаранфилÑки Б, Серафимов Ð, Долгова-Корубин Ð’, Таџер И, ШеÑтаков Ѓ, Симова Ð. и Ñор. Клинички и лабораториÑки карактериÑтики на карциномот на тироидната жлезда во С.Ð . Македонија. Прилози 1982; III (2):
  25. -27.
  26. Vecchia C La, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F et al. Thyroid cancer mortality and incidence: A global overview. Int J Cancer 2015:136; 2187–2195.
  27. Butros R, Boyvat F, Ozyer U, Bilezikci B, Arat Z, Aytekin C et al. Management of infracentrimetric thyroid nodules with respect to ultrasonographic features. Eur Radiol 2007;17: 1358 -1364.
  28. Zhong LC, Lu F, Ma F, Xu X, Li
  29. DD, Guo LH et al. Ultrasound-guided fine-needle aspiration of thyroid nodules: does size lim- its its efficiency?. Int J Clin Exp Pathol 2015; (3): 3155-3159.
  30. Yasuhiro I, Akira M, Hiroyuki I, Mitsuhiro F, Minoru K, Takuya H et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg
  31. ; 34:28-35.
  32. Kaliszewski K, Wojtczak B, Stru- tynska-Karpinska, Lukienczuk T, Forkasiewicz Z, Domoslawski P. Incidental and non-incidental thyroid micro-carcinoma. Oncol- ogy letters 2016; 12:734-740.
  33. Jung Jin C. Screening of Thyroid Cancer and Management of Thy- roid Incidentaloma. Korean J Fam Med 2010;31(2):87-93.
  34. Moriss LG, Sikora AG, Tosteson TD, Davis L. The increasing inci- dence of thyroid cancer: the in- fluence of access to care. Thyroid
  35. ; 23(7):885-91.
  36. Favus MJ, Schneider AB, Stachura ME, Arnold JE, Rio UY, Pinski SM et al. Thyroid cancer occurring as a late consequence of head-and- neck irradiation - evaluation of
  37. patients. N Engl J Med 1976;
  38. :1019-1025.
  39. Refetoff S, Harrison J, Karanfil- ski B, Kaplan EL, De Groot LJ, Bekerman C. Continuing occur- rence of thyroid carcinoma after irradiation to the neck in infancy and childhood. N Engl J Med 1975;
  40. :171-175.
  41. w w w.ceecis.org/iodine/10_mon-
  42. ito ring/.../MA CED O NIA%20 final%20FINALreport.d.
  43. Hodgson NC, Button J, Solorzano CC. Thyroid Cancer: Is the inci- dence still increasing? Ann Surq Oncol, 2004: 11(12): 1093-1097.
  44. Malandrino P, Scollo C, Martura- no I, Russo M, Tavarelli M, Attard M et al. Descriptive epidemiology of human thyroid cancer: experi- ence from a regional registry and the "volcanic factor". Frontiers in Endocrinology 2013; 4:65-72.
  45. World Health Organization. Inter- national Agency for Research on Cancer. GLOBOCAN 2008: Cancer Incidence and Mortality World- wide. Available at: http://globo- can.iarc.fr/